Taking Innovation to Market
Episode Description
Technology transfer is a "lottery business," according to Benjamin Soffer, manager of T3, the commercialization arm of Technion -- the Israel Institute of Technology in Haifa. "You never know which technology will actually make the difference," he says, "so you try to buy as many tickets as possible." In an interview with Israel Knowledge@Wharton, Soffer discussed T3's philosophy, process and some of its recent success stories.
Brief Summary
Ben discusses Techneon technology transfer, its mission, successes like Azle, and future focus on stem cell research.
Key points
- The Role of Techneon. Techneon focuses on technology transfer to ensure innovations reach the marketplace.
- Cultural Heroes of Israel. The shift from military leaders to tech entrepreneurs as cultural icons in Israel.
- Successful Drug Development. Techneon has developed an FDA-approved drug for Parkinson's disease, showcasing its impact.
Ask about Knowledge at Wharton
Episode highlights
- The Role of TechneonTechneon focuses on technology transfer to ensure innovations reach the marketplace.“It's imperative for universities to engage in technology transfer.”0:49Mar 4, 2013
- Cultural Heroes of IsraelThe shift from military leaders to tech entrepreneurs as cultural icons in Israel.“In recent years, IT pioneers became the new culture heroes of Israel.”3:14Mar 4, 2013
- Successful Drug DevelopmentTechneon has developed an FDA-approved drug for Parkinson's disease, showcasing its impact.“Techneon belongs to a distinguished club of universities that developed a drug.”5:30Mar 4, 2013
Tension
40/ 100Low tension
